Hydrogen Transfer Reactions of Amines

Lead Research Organisation: University of Leeds
Department Name: Sch of Chemistry

Abstract

The pharmaceutical, agrochemical and fine chemical industries are coming under increasing economic, ecological and regulatory pressure to develop methods of making their desired compounds which require fewer steps, create minimal waste and do not utilise (or generate) toxic molecules. Nitrogen-containing molecules (eg polysubstituted amines, alcohols, heterocyclic molecules, amides etc) are ubiquitous in drugs, pesticides and other specialty chemicals, but their preparation typically uses multi-step procedures and frequently employs toxic and/or hazardous reagents, as well as generating noxious waste streams. In this project, we will develop new methods for the formation of these valuable molecules using a technique called hydrogen transfer which generates few (or no) by-products, avoids hazardous reagents, and uses readily available and benign amines as the starting materials.This chemistry underpinning this project involves the removal of hydrogen from an amine with a metal catalyst (iridium and ruthenium complexes) / this process forms an oxidised species (an imine) which can undergo chemical reactions that are not available to the starting amine, thus generating a new molecule. There are several themes we will explore based on the basic concept of hydrogen removal from amines, and each addresses a new approach to the construction of organic molecules of major significance in the chemicals industry. In the first theme of this work, hydrogen abstraction from the amine forms an imine which then reacts with a second amine; when the hydrogen is returned by the catalyst this will have coupled together the two amines to give a new amine product (the overall process is one of hydrogen borrowing ). This will be applied to the synthesis of drug molecules such as the migraine treatment Sumatriptan and the antihistamine Benadryl. Related to these ideas will be reactions which are the reverse of this process: namely the fragmentation of an amine into two components, and a variant where the amine is converted into an alcohol. Both reactions are essentially unprecedented and may be applied to a range of synthetic problems such as the conversion of morphine into semi-synthetic opioid derived painkillers.In the second major theme, we will develop methods to make the removal of hydrogen from the amine irreversible, by making the metal catalyst donate the hydrogen (abstracted from the amine) to a suitable acceptor or release it as hydrogen gas. When the imines formed in this initial step now react with a suitable partner, the intermediates generated cannot now accept back hydrogen / instead, further chemistry (including a second hydrogen abstraction oxidation) can take place. For example, in the presence of water, the imines will react with the water and then undergo further oxidation to provide a novel approach to the synthesis of amides. Amides are hugely important features of many drug molecules; usually these compounds are prepared by coupling amines with carboxylic acids using wasteful activating agent. This new approach therefore has environmental benefits. In the final major theme, the oxidative removal of hydrogen from amines will be applied to the synthesis of heterocycles (cyclic structures containing heteroatoms such as oxygen and nitrogen) which are widespread in important chemical products / for example about half of new drug molecules contain at least one heterocycle. There are several classes of heterocycle which will become accessible using metal-catalysed removal of hydrogen, and we will exemplify this chemistry by developing routes to heterocycles found in pharmaceuticals such as Tolazoline, Oxaprozin, Oxyphencyclimine and Tilmacoxib, which are used in a wide range of therapeutic areas.

Publications

10 25 50

publication icon
Blacker AJ (2009) Synthesis of benzazoles by hydrogen-transfer catalysis. in Organic letters

publication icon
Saidi O (2009) Selective amine cross-coupling using iridium-catalyzed "borrowing hydrogen" methodology. in Angewandte Chemie (International ed. in English)

publication icon
Saidi O (2010) Iridium-catalysed amine alkylation with alcohols in water. in Chemical communications (Cambridge, England)

 
Description The work developed during this project allows for the conversion of relatively simple, low-value chemicals into more complex, higher value ones, with the formation of environmentally-benign by-products. Amines are a class of molecule that are found in numerous commercial products, from agrochemicals to pharmaceuticals and effect chemicals. In the current work, catalysts have been developed which can promote the cross-coupling of simple amines to make more complex ones, or of simple amines with other organic molecules known as alcohols, with water as the only by-product. Some of these reactions can be carried out in water as an environmentally-benign solvent. Additionally, the coupling of more complex aromatic amines with aldehydes allows for the generation of molecules known as heterocycles, found in many drug molecules and dyestuffs. These reactions had previously required the use of toxic, environmentally unfriendly reagents, but here the catalysts generate just water and hydrogen gas as the by-products. The results are of potential utility to the chemicals industry generally.
Exploitation Route The catalysts used in this study are commercially available through several suppliers and are freely available for industrial use without IP restrictions. Hence, the work can be readily adapted by industrial and academic labs. The six publications from this programme have been cited over 380 times, indicating a high degree of interest and take-up of the work.
Sectors Chemicals,Pharmaceuticals and Medical Biotechnology

 
Description The catalysts used within this project are commercially available and hence generate economic impact from their purchase and application on scales from discovery platforms upwards.
First Year Of Impact 2012
Sector Chemicals,Pharmaceuticals and Medical Biotechnology
Impact Types Economic

 
Description AstraZeneca Studentship
Amount £27,000 (GBP)
Organisation AstraZeneca 
Department Research and Development AstraZeneca
Sector Private
Country United Kingdom
Start 11/2011 
End 06/2015
 
Description NPIL Pharmaceuticals UK Limited 
Organisation NPIL Pharmaceuticals UK
Country United Kingdom 
Sector Private 
Start Year 2008